Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial

Treatment-resistant schizophrenia (TRS) is a prevalent clinical problem with heterogeneous presentations. However, the clinical trial designs for new treatments are still lacking. This study aimed to assess the efficacy of ziprasidone plus sertraline in TRS patients as compared to ziprasidone monoth...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hui Shi, Jing Xu, Xiaoe Lang, Hanjing Emily Wu, Mei Hong Xiu, Xiang Yang Zhang
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2022-04-01
Collection:Frontiers in Pharmacology
Sujets:
treatment-resistant
ziprasidone
sertraline
efficacy
schizophrenia
acute exacerbation
Accès en ligne:https://www.frontiersin.org/articles/10.3389/fphar.2022.863588/full
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires